F-group (family)
7512.1.1.20 EryCIII-like_C
Ligands and drugs
218
Member domains
78
with ligand contacts (≤ 4 Å)
35.8% of members
81
with DrugDomain annotations
37.2% of members
66
with a DrugBank compound
30.3% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 7512.1.1.20 belongs to X-group 7512 UDP-Glycosyltransferase/glycogen phosphorylase, which binds 8.9 ligand superclasses per 20 proteins, broader than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03103 | TYD | Thymidine-5'- Diphosphate | 24 |
| DB03435 | UDP | Uridine-5'-Diphosphate | 16 |
| DB02159 | PGR | (R)-Propylene glycol | 6 |
| DB00199 | ERY | Erythromycin | 4 |
| DB01861 | UPG | Uridine diphosphate glucose | 4 |
| DB03413 | DUD | Deoxyuridine-5'-Diphosphate | 3 |
| DB03434 | MPO | 3-(N-morpholino)propanesulfonic acid | 2 |
| DB02379 | BGC | Beta-D-Glucose | 1 |
| DB03488 | U2F | Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| TYD | THYMIDINE-5'-DIPHOSPHATE | 24 |
| UDP | URIDINE-5'-DIPHOSPHATE | 16 |
| PGR | R-1,2-PROPANEDIOL | 7 |
| ELO | Elaiophylin | 5 |
| MGmetal | MAGNESIUM ION | 5 |
| 3R2 | 2'-deoxy-5'-O-[(R)-{[(R)-{[(1S,3R,4R,5S)-3,4-dihydroxy-5-methylcyclohexyl]oxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]-3,4-dihydrothymidine | 4 |
| C0T | Calicheamicin T0 | 4 |
| UPG | URIDINE-5'-DIPHOSPHATE-GLUCOSE | 4 |
| CL | CHLORIDE ION | 3 |
| DUD | DEOXYURIDINE-5'-DIPHOSPHATE | 3 |
| ERY | ERYTHROMYCIN A | 3 |
| NAmetal | SODIUM ION | 3 |
| CAmetal | CALCIUM ION | 2 |
| CLJ | Calicheamicin alpha3I | 2 |
| GLC | alpha-D-glucopyranose | 2 |
| Kmetal | POTASSIUM ION | 2 |
| MPO | 3[N-MORPHOLINO]PROPANE SULFONIC ACID | 2 |
| ZIO | (3S,5R,6S,7R,8R,11R,12S,13R,14S,15S)-6-HYDROXY-5,7,8,11,13,15-HEXAMETHYL-4,10-DIOXO-14-{[3,4,6-TRIDEOXY-3-(DIMETHYLAMINO)-BETA-D-XYLO-HEXOPYRANOSYL]OXY}-1,9-DIOXASPIRO[2.13]HEXADEC-12-YL 2,6-DIDEOXY-3-O-METHYL-ALPHA-L-ARABINO-HEXOPYRANOSIDE | 2 |
| 0CX | (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-9-ethyl-2,13-dihydroxy-14-methyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-1H-as-indaceno[3,2-d]oxacyclododecine-7,15-dione | 1 |
| BG9 | (2E,2'E)-3,3'-(1,2-phenylene)di(prop-2-enoic acid) | 1 |